Head of U.S. Health Economics & Value Assessment (HEVA)
Scorpion Therapeutics, Trenton, New Jersey, United States
Role Summary
The Head of U.S. Health Economics & Value Assessment (HEVA) is a senior strategic and scientific leader responsible for shaping and executing the U.S. HEVA strategy for Sanofi’s Specialty Care portfolio, the company’s largest and most complex market and region. This market-facing, enterprise-critical leadership role translates global evidence into US regional impact, delivering US-specific evidence generation and dissemination, shaping payer and policymaker dialogue, and ensuring HEVA evidence directly influences pricing, access, and policy decisions. The position leads a team of U.S. HEVA Therapeutic Area Leads who deliver the evidence and insights needed to ensure access and demonstrate value throughout the product lifecycle. Responsibilities
Define and execute the U.S. HEVA strategy across all Specialty Care therapeutic areas, aligned with global HEOR, U.S. Medical, and Commercial priorities. Serve as a member of both the Global HEOR Leadership Team and the U.S. Specialty Care Leadership Team, ensuring full alignment and integration between global and US regional strategies. Translate HEVA evidence into business and policy impact—driving payer engagement, value positioning, and access strategies. Anticipate and proactively address U.S. policy and reimbursement dynamics through strategic evidence planning and engagement. Represent Sanofi externally as a U.S. HEVA thought leader, advancing the role of evidence in access, policy, and clinical decision-making. Oversee design and execution of U.S.-focused HEVA including RWE programs that demonstrate product value across diverse payer and healthcare systems. Lead launch excellence and post-launch US-specific HEVA strategies, ensuring evidence generation aligns with U.S. access, pricing, and policy needs. Develop and guide compliant and impactful US evidence dissemination pathways—publications, payer dossiers, field materials, and digital platforms. Partner with U.S. Medical Affairs/Value & Access to ensure appropriate use of HEOR evidence in field communications and training. Champion data-driven storytelling that enhances HEVA’s impact and visibility in internal and external forums. Collaborate with Value & Access, US Medical Affairs, and Policy teams to deliver evidence that informs value frameworks and responses, and participate in policy engagement with key stakeholders. Lead engagement with policy stakeholders to represent Sanofi’s HEVA perspectives and scientific rigor. Support external advocacy, guidelines, and evidence education initiatives to shape practice and reimbursement in the US. Lead and develop a high-performing U.S. HEVA team, fostering scientific excellence, collaboration, and accountability. Empower U.S. TA Leads to act as strategic partners to the business and thought leaders in their therapeutic areas. Promote a culture of innovation, inclusion, and continuous learning aligned with HEVA's goals. Model integrity, transparency, and ethical leadership in all scientific and operational activities. Establish and track US HEVA performance metrics that demonstrate measurable business impact. Ensure alignment between U.S. and global HEVA priorities, creating a two-way bridge for knowledge sharing and best practices. Oversee budgeting, resourcing, and operational excellence to ensure effective and compliant delivery for the US business. Maintain full compliance with enterprise, legal, and regulatory standards in evidence generation and dissemination specific to the US. Qualifications
Education: Advanced degree (PhD, MD, MSc, MPH, or PharmD) in a scientific discipline. Experience:
Minimum of 10 years of progressive experience in health economics and outcomes research (HEOR), real world evidence, or related evidence and policy leadership roles. Proven success leading U.S. HEOR strategy and execution across multiple therapeutic areas within large, matrixed organizations. Recognized externally as a HEOR leader with credibility among payers, policymakers, and academic peers. Deep understanding of the U.S. healthcare ecosystem, payer and policy landscape, and evolving regulatory environment. Demonstrated ability to translate evidence into business impact, influence policy, and drive access outcomes. Experience managing scientific teams and cross-functional stakeholders at senior enterprise levels. Approximately 25% travel expected, primarily domestic with occasional international trips.
Skills
Leadership across strategic, operational, and people dimensions with a track record of team development. Excellent communication and influencing skills, including the ability to convey complex evidence to senior management and external stakeholders. Deep understanding of the U.S. healthcare, policy, and regulatory environment with a commitment to compliance and ethics. Entrepreneurial and collaborative mindset with the ability to develop creative solutions to complex problems. Education
Advanced degree (PhD, MD, MSc, MPH, or PharmD) in a scientific discipline.
#J-18808-Ljbffr
The Head of U.S. Health Economics & Value Assessment (HEVA) is a senior strategic and scientific leader responsible for shaping and executing the U.S. HEVA strategy for Sanofi’s Specialty Care portfolio, the company’s largest and most complex market and region. This market-facing, enterprise-critical leadership role translates global evidence into US regional impact, delivering US-specific evidence generation and dissemination, shaping payer and policymaker dialogue, and ensuring HEVA evidence directly influences pricing, access, and policy decisions. The position leads a team of U.S. HEVA Therapeutic Area Leads who deliver the evidence and insights needed to ensure access and demonstrate value throughout the product lifecycle. Responsibilities
Define and execute the U.S. HEVA strategy across all Specialty Care therapeutic areas, aligned with global HEOR, U.S. Medical, and Commercial priorities. Serve as a member of both the Global HEOR Leadership Team and the U.S. Specialty Care Leadership Team, ensuring full alignment and integration between global and US regional strategies. Translate HEVA evidence into business and policy impact—driving payer engagement, value positioning, and access strategies. Anticipate and proactively address U.S. policy and reimbursement dynamics through strategic evidence planning and engagement. Represent Sanofi externally as a U.S. HEVA thought leader, advancing the role of evidence in access, policy, and clinical decision-making. Oversee design and execution of U.S.-focused HEVA including RWE programs that demonstrate product value across diverse payer and healthcare systems. Lead launch excellence and post-launch US-specific HEVA strategies, ensuring evidence generation aligns with U.S. access, pricing, and policy needs. Develop and guide compliant and impactful US evidence dissemination pathways—publications, payer dossiers, field materials, and digital platforms. Partner with U.S. Medical Affairs/Value & Access to ensure appropriate use of HEOR evidence in field communications and training. Champion data-driven storytelling that enhances HEVA’s impact and visibility in internal and external forums. Collaborate with Value & Access, US Medical Affairs, and Policy teams to deliver evidence that informs value frameworks and responses, and participate in policy engagement with key stakeholders. Lead engagement with policy stakeholders to represent Sanofi’s HEVA perspectives and scientific rigor. Support external advocacy, guidelines, and evidence education initiatives to shape practice and reimbursement in the US. Lead and develop a high-performing U.S. HEVA team, fostering scientific excellence, collaboration, and accountability. Empower U.S. TA Leads to act as strategic partners to the business and thought leaders in their therapeutic areas. Promote a culture of innovation, inclusion, and continuous learning aligned with HEVA's goals. Model integrity, transparency, and ethical leadership in all scientific and operational activities. Establish and track US HEVA performance metrics that demonstrate measurable business impact. Ensure alignment between U.S. and global HEVA priorities, creating a two-way bridge for knowledge sharing and best practices. Oversee budgeting, resourcing, and operational excellence to ensure effective and compliant delivery for the US business. Maintain full compliance with enterprise, legal, and regulatory standards in evidence generation and dissemination specific to the US. Qualifications
Education: Advanced degree (PhD, MD, MSc, MPH, or PharmD) in a scientific discipline. Experience:
Minimum of 10 years of progressive experience in health economics and outcomes research (HEOR), real world evidence, or related evidence and policy leadership roles. Proven success leading U.S. HEOR strategy and execution across multiple therapeutic areas within large, matrixed organizations. Recognized externally as a HEOR leader with credibility among payers, policymakers, and academic peers. Deep understanding of the U.S. healthcare ecosystem, payer and policy landscape, and evolving regulatory environment. Demonstrated ability to translate evidence into business impact, influence policy, and drive access outcomes. Experience managing scientific teams and cross-functional stakeholders at senior enterprise levels. Approximately 25% travel expected, primarily domestic with occasional international trips.
Skills
Leadership across strategic, operational, and people dimensions with a track record of team development. Excellent communication and influencing skills, including the ability to convey complex evidence to senior management and external stakeholders. Deep understanding of the U.S. healthcare, policy, and regulatory environment with a commitment to compliance and ethics. Entrepreneurial and collaborative mindset with the ability to develop creative solutions to complex problems. Education
Advanced degree (PhD, MD, MSc, MPH, or PharmD) in a scientific discipline.
#J-18808-Ljbffr